"I live each and every day like it could be my last," the bride, Dannika Evans, tells PEOPLE ...
Boehringer Ingelheim is discarding an inhaled gene therapy designed to treat cystic fibrosis (CF) after terminating a phase 1/2 trial. | Boehringer Ingelheim is discarding an inhaled gene therapy ...
Vertex Pharmaceuticals (NasdaqGS:VRTX) reported strong Q4 results, reflecting continued execution on its broader portfolio ...
SCHLIEREN, ZURICH, SWITZERLAND, February 11, 2026 /EINPresswire.com/ -- InSphero AG, the global market leader in 3D ...
Dern, whose mother, Actress Diane Ladd, died of PF in November, shared about her caregiver experience on television ...
Researchers engineered lipid nanoparticles to deliver a full CFTR gene into human airway cells, restoring near-normal ...
Novel non-invasive liver disease assessments (NILDAs) are effective alternatives to liver biopsy for the treatment of liver ...
The median predicted survival age of a patient with cystic fibrosis in 2020 to 2024 was 65 years, a 19-year increase from ...
StockStory.org on MSN
VRTX Q4 deep dive: Diversification beyond cystic fibrosis sets stage for next growth phase
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported in Q4 CY2025, with sales up 9.5% year on year to $3.19 billion. The company expects the full year’s revenue to be around $13.03 billion, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results